Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy, affecting about 1 in 8,000 people.

Food-packed tables and endless spirits can present a special challenge for those taking GLP-1 medications like Wegovy, ...

As pet ownership is growing fast, so too is the alternative pet-health market, projected to be worth $150 million by 2030.

Around 200 people gathered at Litekyan at the Ritidian National Wildlife Refuge on Saturday in solidarity with the people of ...

The blockbuster drug by Novo Nordisk will be marketed for adults with type-2 diabetes, unlike in the US and Europe where it is also sold as Wegovy for weight loss. Ozempic is a once-weekly injectable ...